Anil Thankappan
About Anil Thankappan
Anil Thankappan is a Research Scientist at Bristol-Myers Squibb and a Staff Biologist at Merck & Co, with extensive experience in molecular biology and therapeutic research.
Title
Anil Thankappan holds the title of Research Scientist. He is currently associated with multiple leading pharmaceutical firms including Bristol-Myers Squibb as a Research Scientist in Princeton, New Jersey, and Merck & Co. as a Staff Biologist in both West Point, Philadelphia, PA, and Rahway, New Jersey.
Company
Anil Thankappan is currently engaged with top-tier pharmaceutical companies. He works at Bristol-Myers Squibb located in Princeton, New Jersey, and also holds the position of Staff Biologist at Merck & Co. in both West Point, Philadelphia, PA, and Rahway, New Jersey. His roles in these companies reflect his extensive experience and specialization in various therapeutic areas.
Education and Expertise
Anil Thankappan pursued his Master's of Science (MS) in Molecular Biology from East Carolina University, completing his studies between 2002 and 2004. He also attended the College of Fisheries. His expertise encompasses in-depth knowledge of ICH-GCP and FDA guidelines, and therapeutic specializations in Immuno-Oncology, Immunology, Diabetes, Cardiovascular, Infectious diseases, and Thrombosis.
Background
Anil Thankappan started his career as a Research Technician at East Carolina University from 2004 to 2005. He then served as a Research Assistant at Trudeau Institute for three years, from 2005 to 2008, before moving on to his current roles at Bristol-Myers Squibb and Merck & Co. His background includes a strong emphasis on collaboration with Contract Research Organizations (CRO) and proficiently managing study timelines to ensure timely data delivery.
Achievements
Anil Thankappan has systematically created, managed, and maintained study timelines throughout his career. He has coordinated with Contract Research Organizations to enhance business operations and cost efficiency. Anil has demonstrated skills in compiling and communicating study materials and summary reports to senior management. Additionally, he is experienced in reviewing and editing study protocols, data capture, analysis, and interpretation, showcasing his commitment to consistency, accuracy, and innovation in drug development.